Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 22% ± 5% | |
| glutamatergic neuron | 4 studies | 42% ± 16% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| GABAergic neuron | 3 studies | 43% ± 5% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 4% | |
| interneuron | 3 studies | 35% ± 18% | |
| neuron | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 36% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2377.81 | 2639 / 2642 | 100% | 30.04 | 705 / 705 |
| prostate | 100% | 1472.39 | 245 / 245 | 100% | 12.58 | 500 / 502 |
| kidney | 100% | 1793.70 | 89 / 89 | 99% | 16.95 | 896 / 901 |
| esophagus | 100% | 1139.49 | 1444 / 1445 | 99% | 10.30 | 182 / 183 |
| adrenal gland | 100% | 1844.64 | 258 / 258 | 99% | 16.94 | 227 / 230 |
| liver | 100% | 1494.97 | 226 / 226 | 98% | 10.74 | 398 / 406 |
| thymus | 100% | 1072.55 | 652 / 653 | 98% | 7.84 | 591 / 605 |
| breast | 100% | 1048.62 | 458 / 459 | 98% | 9.12 | 1092 / 1118 |
| uterus | 100% | 1647.24 | 170 / 170 | 97% | 10.12 | 446 / 459 |
| bladder | 100% | 1237.76 | 21 / 21 | 97% | 8.50 | 488 / 504 |
| lung | 98% | 1003.54 | 566 / 578 | 99% | 10.23 | 1142 / 1155 |
| intestine | 100% | 1263.38 | 965 / 966 | 97% | 7.60 | 509 / 527 |
| stomach | 100% | 948.52 | 358 / 359 | 97% | 8.66 | 276 / 286 |
| skin | 96% | 1345.41 | 1733 / 1809 | 100% | 36.77 | 472 / 472 |
| pancreas | 95% | 489.10 | 310 / 328 | 98% | 8.85 | 175 / 178 |
| ovary | 100% | 1485.13 | 180 / 180 | 92% | 6.77 | 396 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.44 | 29 / 29 |
| spleen | 100% | 1418.38 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 8.54 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.94 | 1 / 1 |
| adipose | 100% | 1161.12 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1003.07 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 13.07 | 76 / 80 |
| heart | 89% | 532.40 | 769 / 861 | 0% | 0 | 0 / 0 |
| muscle | 73% | 303.72 | 587 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 51% | 627.59 | 477 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015790 | Biological process | UDP-xylose transmembrane transport |
| GO_1990569 | Biological process | UDP-N-acetylglucosamine transmembrane transport |
| GO_0006111 | Biological process | regulation of gluconeogenesis |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005464 | Molecular function | UDP-xylose transmembrane transporter activity |
| GO_0005462 | Molecular function | UDP-N-acetylglucosamine transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC35B4 |
| Protein name | Nucleotide sugar transporter SLC35B4 (Solute carrier family 35 member B4) (UDP-xylose and UDP-N-acetylglucosamine transporter) (YEA4 homolog) Solute carrier family 35 member B4 |
| Synonyms | PSEC0055 YEA4 |
| Description | FUNCTION: Antiporter that transports nucleotide sugars across the endoplasmic reticulum (ER) membrane in exchange for another nucleotide sugar. May couple UDP-alpha-D-glucuronate (UDP-GlcA) or UDP-alpha-D-xylose (UDP-Xyl) efflux to UDP-alpha-D-glucuronate (UDP-GlcA) influx into the ER lumen, which in turn stimulates glucuronidation and excretion of endobiotics and xenobiotics. .; FUNCTION: [Isoform 1]: Has UDP-GlcA:UDP-GlcNAc antiporter activity. .; FUNCTION: [Isoform 2]: Has UDP-GlcA:UDP-GlcNAc antiporter activity. . |
| Accessions | ENST00000416907.5 ENST00000470969.2 [Q969S0-2] Q969S0 ENST00000378509.9 [Q969S0-1] F8WAW0 |